Notícias

Millions of dollars are available to eligible Chantix buyers, but consumers have until September 14 to submit a claim.

July 15 () - Shares of Celcuity fell about 8% in premarket trading on Wednesday, as the delayed commercial launch ‌of its newly approved breast cancer drug and treatment-tolerability ‌concerns overshadowed the company's first U. Food and Drug Administration on ​Tuesday approved gedatolisib, branded as Revtorpyk, for certain patients with advanced breast cancer whose tumors do not carry a PIK3CA mutation.

Still, shares fell by nearly 20% after the company revealed a delay in the coming launch of Revtorpyk. Details in the drug’s prescribing information surprised some analysts, too.

Gedatolisib, in-licensed from Pfizer in 2021, is Celcuity’s sole late-stage asset.

Several Midtown blocks were shut down earlier this week after structural problems put the high-rise building at risk of partial collapse.

June 30 (Reuters) - A bipartisan group of U. lawmakers has opened national security investigations into whether drugmakers Merck and AbbVie have been involved in clinical trials conducted in China that helped fuel the communist country's military capability, according ‌to letters seen by Reuters.

(Updates with Pfizer's response in the last two paragraphs.) Pfizer (PFE) has been dismissed as a